To evaluate whether exercise enhances the GvL effects of DLI, leukemia-bearing NSG-IL15 mice were infused with PBMCs three days after leukemia challenge with the human chronic myeloid leukemia cell line, K562. The gene discussed is IL15; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.